The Impella device (Impella, Abiomed, Danvers, MA) is a percutaneous transvalvular
microaxial flow pump that is currently used for (1) cardiogenic shock,(2) left ventricular …

Abstract Treatment strategies to combat cardiogenic shock (CS) have remained stagnant
over the past decade. Mortality rates among patients who suffer CS after acute myocardial …

Aims This study aimed to give contemporary insight into the use of Impella and venoarterial
extracorporeal membrane oxygenation (VAECMO) in acute myocardial infarctionrelated …

Purpose Cardiogenic shock is associated with high mortality. In refractory shock, it is unclear
if mechanical circulatory support (MCS) devices improve survival. We conducted a network …

Objectives: Despite an increase in the use of mechanical circulatory support (MCS) devices
for acute myocardial infarction cardiogenic shock (AMI-CS), there is currently no randomised …

Background Mechanical circulatory support (MCS) devices are increasingly used for
hemodynamic support in cardiogenic shock or highrisk percutaneous coronary …

The importance of temporary mechanical circulatory support for treating acute heart failure
with cardiogenic shock is increasingly recognized, and Impella (Abiomed, Danvers, MA …

The use of mechanical circulatory support (MCS) in cardiogenic shock (CS) is increasing.
We conducted a systematic review and meta-analysis to compare the outcomes of Impella …

Introduction Despite advances in heart failure therapies and percutaneous coronary
interventions, survival for cardiogenic shock remains poor. Percutaneous ventricular assist …

Cardiogenic shock (CS) is part of a clinical syndrome consisting of acute left ventricular
failure causing severe hypotension leading to inadequate organ and tissue perfusion. The …